Amedisys to Present at the 28th Annual J.P. Morgan Healthcare Conference

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home care and hospice companies, today announced that William F. Borne, Chief Executive Officer, and Dale E. Redman, Chief Financial Officer, will present at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 14, 2010.

The presentation will begin at 8:30 a.m. Pacific/11:30 a.m. Eastern time. The audio presentation will be webcast live and can be accessed through a link on our Investor Relations page at the following web address: http://www.amedisys.com/investors.

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Our common stock trades on the Nasdaq Global Select Market under the symbol "AMED.”

Our company website address is www.amedisys.com. We use our website as a channel of distribution for important company information. Important information, including press releases, analyst presentations and financial information regarding the Company is routinely posted on and accessible on the "Investor Relations” subpage of our website, which is accessible by clicking on the tab labeled "Investors” on our website home page. We will also use our website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the Securities and Exchange Commission ("SEC”) disclosing the same information. In addition, we make available on the Investor Relations subpage of our website (under the link "SEC filings”) free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable after we electronically file such reports with the SEC. Further, copies of our Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct and the charters for the Audit, Compensation and Nominating and Governance Committees of our Board are also available on the Investor Relations subpage of our website (under the link "Corporate Governance”).